Government in the Sunshine Act Meeting Notice, 43526 [06-6644]
Download as PDF
<![CDATA[
43526
Federal Register / Vol. 71, No. 147 / Tuesday, August 1, 2006 / Notices
Date, and significant changes, if any,
that are likely to occur within a
reasonably foreseeable time. Supply
conditions to consider include
technology; production methods;
development efforts; ability to increase
production (including the shift of
production facilities used for other
products and the use, cost, or
availability of major inputs into
production); and factors related to the
ability to shift supply among different
national markets (including barriers to
importation in foreign markets or
changes in market demand abroad).
Demand conditions to consider include
end uses and applications; the existence
and availability of substitute products;
and the level of competition among the
Domestic Like Product produced in the
United States, Subject Merchandise
produced in the Subject Countries, and
such merchandise from other countries.
(11) (Optional) A statement of
whether you agree with the above
definitions of the Domestic Like Product
and Domestic Industry; if you disagree
with either or both of these definitions,
please explain why and provide
alternative definitions.
Authority: These reviews are being
conducted under authority of title VII of the
Tariff Act of 1930; this notice is published
pursuant to section 207.61 of the
Commission’s rules.
By order of the Commission.
Issued: July 26, 2006.
Marilyn R. Abbott,
Secretary to the Commission.
[FR Doc. E6–12275 Filed 7–31–06; 8:45 am]
BILLING CODE 7020–02–P
INTERNATIONAL TRADE
COMMISSION
[USITC SE–06–048]
Government in the Sunshine Act
Meeting Notice
United
States International Trade Commission.
TIME AND DATE: August 7, 2006 at 11 a.m.
PLACE: Room 101, 500 E Street SW.,
Washington, DC 20436, Telephone:
(202) 205–2000.
STATUS: Open to the public.
MATTERS TO BE CONSIDERED: 1. Agenda
for future meetings: none.
2. Minutes.
3. Ratification List.
4. Inv. No. 731–TA–1104
(Preliminary) (Certain Polyester Staple
Fiber from China)—briefing and vote.
(The Commission is currently scheduled
to transmit its determination to the
Secretary of Commerce on August 7,
rwilkins on PROD1PC63 with NOTICES
AGENCY HOLDING THE MEETING:
VerDate Aug<31>2005
20:04 Jul 31, 2006
Jkt 208001
2006; Commissioners’ opinions are
currently scheduled to be transmitted to
the Secretary of Commerce on or before
August 14, 2006.).
5. Outstanding action jackets: none.
In accordance with Commission
policy, subject matter listed above, not
disposed of at the scheduled meeting,
may be carried over to the agenda of the
following meeting.
By order of the Commission.
Issued: July 27, 2006.
Marilyn R. Abbott,
Secretary to the Commission.
[FR Doc. 06–6644 Filed 7–28–06; 1:12 pm]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application
Prior to issuing a registration under 21
U.S.C. 952(a)(2)(B), and in accordance
with 21 CFR 1301.34(a), this is notice
that on April 13, 2005, Kenco VPI,
Division of Kenco Group Inc., 350
Corporate Place, Chattanooga, TN
37419, has made application to the Drug
Enforcement Administration (DEA) by
letter to be registered as an importer of
Nabilone (7379), a basic class of
controlled substance listed in Schedule
II.
The company plans to import the
listed controlled substance for
distribution to its customers.
Kenco VPI has been an importer of
Schedule III–V controlled substances
since June 14, 2004. On April 14, 2005,
the DEA added Schedule II to the firm’s
importer registration. The DEA also
added the drug code for Nabilone, a
Schedule II controlled substance, to the
firm’s registration on April 28, 2005.
Both amendments to the registration
were made without benefit of the
required legal process for modifying the
DEA registration. Kenco VPI is currently
complying with the legal requirements
to register as a Schedule III importer. In
addition the firm was given
authorization to import the Nabilone
product into the United States on May
12, 2005. The Nabilone product was
approved by the Food & Drug
Administration on May 15, 2006. DEA
has agreed to allow Kenco VPI to
continue to import the Nabilone product
into the United States, while the firm is
completing the required legal process.
Any manufacturer who on April 13,
2005, was registered, or applying to be
registered with DEA to manufacture
such basic class of controlled substance
PO 00000
Frm 00094
Fmt 4703
Sfmt 4703
may file comments or objections to the
issuance of the proposed registration
and may, at the same time, file a written
request for a hearing on such
application pursuant to 21 CFR 1301.43
and in such form as prescribed by 21
CFR 1316.47. For purposes of this
Notice, DEA has chosen recognized
applicable manufacturers registered on
April 13, 2005, the date on which Kenco
submitted its initial request to have
Nabilone added to its DEA importer
registration. By employing this date,
DEA seeks to equitably address its
initial failure to publish Kenco’s request
to import Nabilone, while at the same
time allowing those entities that would
have been in a position to request a
hearing on April 13, 2005, had DEA
filed a timely notice, the right to request
a hearing.
Any such written comments or
objections being sent via regular mail
may be addressed, in quintuplicate, to
the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative/ODL; or
any being sent via express mail should
be sent to DEA Headquarters, Attention:
DEA Federal Register Representative/
ODL, 2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than August 31, 2006.
This procedure is to be conducted
simultaneously with and independent
of the procedures described in 21 CFR
1301.34(b), (c), (d), (e), and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
(40 FR 43745–46), all applicants for
registration to import a basic class of
any controlled substance listed in
Schedule I or II are, and will continue
to be, required to demonstrate to the
Deputy Assistant Administrator, Office
of Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a), 21 U.S.C. 823(a), and 21
CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
Dated: July 26, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–12256 Filed 7–31–06; 8:45 am]
BILLING CODE 4410–09–P
E:\FR\FM\01AUN1.SGM
01AUN1
]]>Agencies
[Federal Register Volume 71, Number 147 (Tuesday, August 1, 2006)]
[Notices]
[Page 43526]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-6644]
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[USITC SE-06-048]
Government in the Sunshine Act Meeting Notice
Agency Holding the Meeting: United States International Trade
Commission.
Time and Date: August 7, 2006 at 11 a.m.
Place: Room 101, 500 E Street SW., Washington, DC 20436, Telephone:
(202) 205-2000.
Status: Open to the public.
Matters To Be Considered: 1. Agenda for future meetings: none.
2. Minutes.
3. Ratification List.
4. Inv. No. 731-TA-1104 (Preliminary) (Certain Polyester Staple
Fiber from China)--briefing and vote. (The Commission is currently
scheduled to transmit its determination to the Secretary of Commerce on
August 7, 2006; Commissioners' opinions are currently scheduled to be
transmitted to the Secretary of Commerce on or before August 14,
2006.).
5. Outstanding action jackets: none.
In accordance with Commission policy, subject matter listed above,
not disposed of at the scheduled meeting, may be carried over to the
agenda of the following meeting.
By order of the Commission.
Issued: July 27, 2006.
Marilyn R. Abbott,
Secretary to the Commission.
[FR Doc. 06-6644 Filed 7-28-06; 1:12 pm]
BILLING CODE 7020-02-P
